ArmaGen aims to transform the treatment of severe neurological disorders by enabling transport of recombinant proteins, peptides and nucleic acids across the blood-brain barrier (BBB), addressing a clear unmet medical need in a majority of these diseases. We believe our therapeutic approach can make a real difference for patients and families living with these diseases.

Click here for an overview of ArmaGen’s research published in peer-reviewed publications.

Engineering and developing revolutionary therapies for the brain.